Use of cyclooxygenase inhibitor and the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A nested case‐control study using a nationwide population‐based data-Reference-Cited by-同舟云学术

Use of cyclooxygenase inhibitor and the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A nested case‐control study using a nationwide population‐based data

Published:2019-10-02 Issue:1 Volume:27 Page:68-73
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Cho Kyoung Sun¹,Sohn Won²^ORCID,Lee Yeong Chan¹^ORCID,Chi Sang Ah³,Cho Ju‐Yeon⁴^ORCID,Kim Kyunga³⁵,Paik Yong‐Han¹³⁶

Affiliation:

1. Department of Digital Health Samsung Advanced Institute for Health Science and Technology Sunkyunkwan University Seoul Korea

2. Department of Internal Medicine Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine Korea

3. Department of Health Science and Technology Samsung Advanced Institute for Health Science and Technology Sunkyunkwan University Seoul Korea

4. Division of Gastroenterology and Hepatology Department of Medicine Chosun University Gwang‐Ju Korea

5. Biostatistics and Clinical Epidemiology Center Samsung Medical Center Seoul Korea

6. Department of Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul Korea

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13201

Reference19 articles.

1. Cyclooxygenase in biology and disease

2. Cyclooxygenase-2: A Therapeutic Target

3. Cyclooxygenase inhibitors: Scope of their use and development in cancer chemotherapy

4. Cyclooxygenase-2 and Cancer Treatment: Understanding the Risk Should Be Worth the Reward: Fig. 1.

5. Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Aspirin Use on Incident Hepatocellular Carcinoma—An Updated Systematic Review and Meta-Analysis;Cancers;2023-07-06

2. Association between first-step analgesic use and cancer in patients with diabetes;Int. Journal of Clinical Pharmacology and Therapeutics;2023-02-01

3. Systematic review with meta‐analysis: The effects of non‐steroidal anti‐inflammatory drugs and anti‐platelet therapy on the incidence and recurrence of hepatocellular carcinoma;Alimentary Pharmacology & Therapeutics;2021-07-11

4. Hepatitis B virus‐related hepatocellular carcinoma in the era of antiviral therapy: The emerging role of non‐viral risk factors;Liver International;2020-08-03